Under a rule that kicked in Jan. 1, hospitals are required to make public the prices they negotiate with insurers. That’s a lot more information than was previously required, which was only the posting of “chargemasters” — the hospital-generated list prices that few consumers or health plans actually pay.
Caregiving is in crisis for low-income caregivers. Family and friends who provide help with daily tasks for anyone with complex health needs or decreased mobility face high demands and are in short supply. This work is largely unpaid and unseen, and families are left to fend for themselves with few options to ease their caregiving duties.
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.
Whether you’re Republican or Democrat, there’s one thing we can all agree on: Americans are paying too much for their prescription drugs. Over the last six years, the median cost of prescription drugs has increased over 70 percent, leaving Americans with an ever-increasing burden for prescriptions that their lives literally depend on. As someone whose family is personally impacted by high prescription drug costs, I understand the struggles that Americans are facing.
A routine doctor’s visit for a sore throat brought more than $28,000 in charges for one New York City woman in our latest “Bill of the Month” installment.
In our ongoing, crowdsourced investigation with NPR and CBS, we’ve armed future health system pilgrims with the tools they need to avoid exorbitant medical bills and fight back against unfair charges. Here’s a look back at 2019’s stories.
Consumers are admonished to be “smart shoppers,” but that’s difficult if health care prices are clear as mud. When Sarah Macsalka’s son needed stitches, she did her best to avoid the ER and still ended up with a $3,000 bill.
Health care is still a top issue in the Democratic primary debate for president, but the candidates’ complicated plans may be doing more to confuse than to educate voters. Margot Sanger-Katz of The New York Times, Caitlin Owens of Axios and Julie Appleby of Kaiser Health News join KHN’s Julie Rovner to discuss this and more health news. Also, for extra credit, the panelists recommend their favorite health policy stories of the week.
The final directive drew swift responses from the hospital and insurance industries. The Trump administration also released a proposed rule that would require health insurers to spell out for all services beforehand just how much patients may owe for their out-of-pocket costs.
In America, there is medicine to treat the common cold, regulate diabetes, lower blood pressure and even help cure cancer. But pharmaceutical drugs do Americans little good if they can’t afford them.